Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01034202
Recruitment Status : Completed
First Posted : December 17, 2009
Last Update Posted : February 9, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S